0000950136-05-006829 8-K 2 20051028 2.02 9.01 20051101 20051101 Celanese CORP 0001306830 2820 980420726 DE 1231 8-K 34 001-32410 051168467 1601 W. LBJ FREEWAY DALLAS TX 75234 972-443-4000 1601 W. LBJ FREEWAY DALLAS TX 75234 Blackstone Crystal Holdings Capital Partners (Cayman) IV Ltd. 20041022 8-K 1 file001.htm FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): OCTOBER 28, 2005 ------------------ CELANESE CORPORATION -------------------- (Exact Name of Registrant as specified in its charter) DELAWARE 001-32410 98-0420726 ---------------------------- ---------------- ------------------- (State or other jurisdiction (Commission File (IRS Employer of incorporation) Number) Identification No.) 1601 WEST LBJ FREEWAY, DALLAS, TEXAS 75234-6034 ----------------------------------------------- (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (972) 901-4500 --------------- NOT APPLICABLE ------------------ (Former name or former address, if changed since last report): Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Item 2.02 Results of Operations and Financial Condition On October 28, 2005, Celanese Corporation (the "Company") issued a press release affirming guidance for diluted adjusted earnings per share and adjusted EBITDA for the third quarter and on adjusted EBITDA for full year 2005 and raising guidance for diluted adjusted earnings per share full year 2005. A copy of the press release is attached to this Current Report on Form 8-K ("Current Report") as Exhibit 99.1 and is incorporated herein solely for purposes of this Item 2.02 disclosure. The information in this Current Report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section. The information in this Current Report, including Exhibit 99.1, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended or the Exchange Act, regardless of any incorporation by reference language in any such filing. Item 9.01 Financial Statements and Exhibits. (c) Exhibits Exhibit Number Description -------------- ----------- 99.1 Press Release dated October 28, 2005 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CELANESE CORPORATION By: /s/ John J. Gallagher, III ------------------------------------ Name: John J. Gallagher, III Title: Executive Vice President and Chief Financial Officer Date: November 1, 2005 EXHIBIT INDEX Exhibit Number Description -------------- ----------- 99.1 Press Release dated October 28, 2005 EX-99.1 2 file002.htm PRESS RELEASE [CELANESE LOGO OMITTED] INVESTOR INFORMATION Celanese Corporation Investor Relations 1601 West LBJ Freeway Dallas, TX 75234-6034 Mark Oberle Phone: +1-972-443-4464 Fax: +1-972-332-9373 Mark.Oberle@celanese.com CELANESE CORPORATION CONFIRMS THIRD QUARTER GUIDANCE; RAISES FULL YEAR GUIDANCE RANGE FOR DILUTED ADJUSTED EPS TO $1.95 TO $2.05 PER SHARE ON PROGRESS IN CELANESE AG SHARE OWNERSHIP DALLAS, Texas, October 28, 2005 - Celanese Corporation today announced that third quarter diluted adjusted earnings will be within the company's guidance range of between $0.45 and $0.50 per share. The company also announced that it is raising full year 2005 guidance on diluted adjusted earnings per share from $1.90 to $2.00 per share to $1.95 to $2.05 per share based on the benefits of the company's recently increased ownership of Celanese AG. The company reaffirmed its guidance for adjusted EBITDA of $240 million to $260 million for the third quarter and $1,060 million to $1,090 million for the full year. "In spite of the challenges of Hurricane Rita and higher raw material and energy costs, our businesses continue to perform within expectations," said Weidman. "While our more specialty, downstream businesses will come under pressure in this environment, the company's rigorous focus on cost control and productivity improvement will help to maintain our projected earnings performance. We are raising our 2005 guidance to reflect the positive financial impact of the share purchase progress we have made with shareholders of Celanese AG." The increased ownership of Celanese AG results in lower minority interest and a reduction in the quarterly charge for the guaranteed annual payment to Celanese AG shareholders. As a result of the agreement reached with two minority shareholders in August and the ongoing tender offer, Celanese Corporation owned approximately 96% of Celanese AG's outstanding shares as of September 30, 2005 and approximately 98% as of October 27, 2005. The company estimates the 2005 full year impact on diluted adjusted earnings per share to be between $0.04 and $0.08 per share. Due to a timing conflict with another chemical company, Celanese Corporation has changed the time it will hold its third quarter conference call. The conference call is now scheduled for 1 p.m., Eastern Time, instead of at 11 a.m., on Monday, November 7. The nine months ended September 30, 2005 and the third quarter results, which are not yet available, will be released on November 7 prior to the call. ABOUT CELANESE Celanese Corporation (NYSE:CE) is an integrated global producer of value-added industrial chemicals based in Dallas, Texas. The Company has four major businesses: Chemicals Products, Technical Polymers Ticona, Acetate Products and Performance Products. Celanese has production plants in 13 countries in North America, Europe and Asia. In 2004, Celanese Corporation and its predecessor had combined net sales of $5.1 billion. The presentation of combined net sales of Celanese Corporation with its predecessor is not in accordance with U.S. GAAP. For more information on Celanese Corporation including a reconciliation of the combined net sales, please visit the company's web site at www.celanese.com. FORWARD-LOOKING STATEMENTS: This release may contain "forward-looking statements," which include information concerning the company's plans, objectives, goals, strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. When used in this release, the words "estimates," "expects," "anticipates," "projects," "plans," "intends," "believes," and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the company's control, could cause actual results to differ materially from those expressed as forward-looking statements. Certain of these risk factors are discussed in the company's filing with the SEC. Any forward-looking statement speaks only as of the date on which it is made, and the company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. Reconciliation of Non-U.S. GAAP Measures to U.S. GAAP This release reflects two performance measures, adjusted EBITDA, and diluted adjusted earnings per share as non-U.S. GAAP measures. The most directly comparable financial measure presented in accordance with U.S. GAAP in our consolidated financial statements for adjusted EBITDA is net earnings (loss); and for diluted adjusted earnings per share is diluted earnings per share. For a reconciliation of these non-U.S. GAAP measures to U.S. GAAP figures, see the accompanying schedules to this release. Use of Non-U.S. GAAP Financial Information Adjusted EBITDA, a measure used by management to measure performance, is defined as earnings (loss) from continuing operations, plus interest expense net of interest income, income taxes and depreciation and amortization, and further adjusted for certain cash and non-cash charges. Our management believes adjusted EBITDA is useful to investors because it is one of the primary measures our management uses for its planning and budgeting processes and to monitor and evaluate financial and operating results. Adjusted EBITDA is not a recognized term under U.S. GAAP and does not purport to be an alternative to net earnings as a measure of operating performance or to cash flows from operating activities as a measure of liquidity. Because not all companies use identical calculations, this presentation of adjusted EBITDA may not be comparable to other similarly titled measures of other companies. Additionally, adjusted EBITDA is not intended to be a measure of free cash flow for management's discretionary use, as it does not consider certain cash requirements such as interest payments, tax payments and debt service requirements nor does it represent the amount used in our debt covenants. Diluted adjusted earnings per share is defined as net earnings available to common shareholders adjusted for special and one-time expenses divided by the number of common shares outstanding as of the end of the previously reported period and assuming conversion of all preferred shares into common stock and dilution from the exercise of options under the treasury stock method under FAS 128. We believe that the presentation of all of the non-U.S. GAAP information provides useful information to management and investors regarding various financial and business trends relating to our financial condition and results of operations, and that when U.S. GAAP information is viewed in conjunction with non-U.S. GAAP information, investors are provided with a more meaningful understanding of our ongoing operating performance. This non-U.S. GAAP information is not intended to be considered in isolation or as a substitute for U.S. GAAP financial information. GUIDANCE DILUTED ADJUSTED EPS Q3 2005 MID- Q3 2005 MID- FY 2005 MID- FY 2005 MID- POINT GUIDANCE POINT GUIDANCE POINT GUIDANCE POINT GUIDANCE in $ millions, except for share and per share data DILUTED EPS DILUTED ADJ. EPS DILUTED EPS DILUTED ADJ. EPS ======================================================= ================ ================== ================ ================== NET EARNINGS FOR DILUTED EPS 48 48 134 134 ------------------------------------------------------------------------ ------------------ ---------------- ------------------ Special charges and inventory purchase accounting adjustments 30 Special charges, inventory purchase accounting adjustments, monitor fee, refinancing costs and non-operating foreign exchange position 218 Tax rate differential 3 (19) ------------------------------------------------------------------------ ------------------ ---------------- ------------------ NET EARNINGS FOR DILUTED EPS 48 81 134 333 ======================================================================== ================== ================ ================== DILUTED SHARES (THOUSANDS) Weighted average shares outstanding 158,530 158,530 158,530 158,530 Conversion of Preferred Shares 12,000 12,000 12,000 12,000 Assumed conversion of stock options - - - - ------------------------------------------------------------------------ ------------------ ---------------- ------------------ Total diluted shares 170,530 170,530 170,530 170,530 ------------------------------------------------------------------------------------------- ----------------------------------- DILUTED EPS 0.28 0.47 0.79 1.95 ======================================================================== ================== ================ ================== IMPACT OF INCREASED CELANESE AG OWNERSHIP: Impact in Other income/expense 0.02 0.02 Impact on Minority interest 0.03 0.03 ------------------------------------------------------------------------------------------- ----------------------------------- REVISED FULL YEAR GUIDANCE 0.84 2.00 ================================================================================================================================ GUIDANCE ADJUSTED EBITDA -- MIDPOINT GUIDANCE GUIDANCE in $ millions Q3 2005 FY 2005 ============================================================================================== Net earnings (loss) 48 134 (Earnings) loss from discontinued operations - - Interest expense 90 412 Interest income (5) (34) Income tax provision (benefit) 32 105 Depreciation and amortization 66 252 -------------------------------------------------------------------------------- ------------- EBITDA 231 869 Adjustments: Cash dividends received in excess of equity in net earnings of affiliates (7) (4) Special charges 15 105 Other unusual items and adjustments * 11 105 ---------------------------------------------------------------------------------------------- ADJUSTED EBITDA 250 1,075 ============================================================================================== *Primarily includes the following: Excess of minority interest income over cash dividends paid to minority shareholders Severance and other restructuring charges not included in special charges Cash interest income used by captive insurance subsidiaries to fund operations Unusual and non-recurring items Advisor monitoring fee